High materiality7/10
RBC Capital Reiterates Outperform Rating on Arrowhead Pharma (ARWR)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC reiterates Outperform with a $100 target; current price $82.32; upside potential.
- RBC Outperform; target $100; price $82.32
Key facts
- 01
Target: $100
- 02
Posted price: $82.32
- 03
Analyst firm: RBC Capital
- 04
Analyst: Luca Issi
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.